Cargando…

Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy

Matrix metalloproteinases (MMPs) are secreted proteinases that have physiologic roles in degradation and remodeling of extracellular matrix (ECM) in almost all tissues. However, their excessive production in disease conditions leads to many pathological features including tissue breakdown, inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogura, Yuji, Tajrishi, Marjan M., Sato, Shuichi, Hindi, Sajedah M., Kumar, Ashok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207008/ https://www.ncbi.nlm.nih.gov/pubmed/25364719 http://dx.doi.org/10.3389/fcell.2014.00011

Ejemplares similares

Current Pharmacological Strategies for Duchenne Muscular Dystrophy
por: Yao, Shanshan, et al.
Publicado: (2021)

Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy
por: Dort, Junio, et al.
Publicado: (2023)

Matrix Metalloproteinase-9 Inhibition Improves Proliferation and Engraftment of Myogenic Cells in Dystrophic Muscle of mdx Mice
por: Hindi, Sajedah M., et al.
Publicado: (2013)

Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
por: Marini, Vittoria, et al.
Publicado: (2022)

Editorial: Muscular dystrophies: Current therapeutic advances to improve and restore muscle homeostasis
por: Bargiela, Ariadna, et al.
Publicado: (2022)

Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy
por: Mendell, Jerry R., et al.
Publicado: (2023)

Beneficial impacts of neuromuscular electrical stimulation on muscle structure and function in the zebrafish model of Duchenne muscular dystrophy
por: Kilroy, Elisabeth A, et al.
Publicado: (2022)

Modeling Patient-Specific Muscular Dystrophy Phenotypes and Therapeutic Responses in Reprogrammed Myotubes Engineered on Micromolded Gelatin Hydrogels
por: Barthélémy, Florian, et al.
Publicado: (2022)

Characterization of cardiac involvement in children with LMNA-related muscular dystrophy
por: Cesar, Sergi, et al.
Publicado: (2023)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Effects of mutant lamins on nucleo-cytoskeletal coupling in Drosophila models of LMNA muscular dystrophy
por: Shaw, Nicholas M., et al.
Publicado: (2022)

Targeting the Ubiquitin-Proteasome System in Limb-Girdle Muscular Dystrophy With CAPN3 Mutations
por: Lasa-Elgarresta, Jaione, et al.
Publicado: (2022)

Editorial: Emerging Mechanisms for Skeletal Muscle Mass Regulation
por: Ogura, Yuji, et al.
Publicado: (2021)

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
por: Sun, Chengmei, et al.
Publicado: (2020)

Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
por: Fortunato, Fernanda, et al.
Publicado: (2021)

A Journey on Extracellular Vesicles for Matrix Metalloproteinases: A Mechanistic Perspective
por: Thuault, Sylvie, et al.
Publicado: (2022)

TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair
por: Ogura, Yuji, et al.
Publicado: (2015)

Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells
por: Bobadilla Muñoz, Miriam, et al.
Publicado: (2023)

Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
por: Bez Batti Angulski, Addeli, et al.
Publicado: (2023)

Pharyngeal pathology in a mouse model of oculopharyngeal muscular dystrophy is associated with impaired basal autophagy in myoblasts
por: Zhang, Yu, et al.
Publicado: (2022)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
por: Goyenvalle, Aurélie, et al.
Publicado: (2011)

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2015)

Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
por: Happi Mbakam, Cedric, et al.
Publicado: (2022)

Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2013)

Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2012)

Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2014)

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2015)

Expression of Drosophila Matrix Metalloproteinases in Cultured Cell Lines Alters Neural and Glial Cell Morphology
por: Hearst, Scoty, et al.
Publicado: (2021)

The PERK arm of the unfolded protein response regulates satellite cell-mediated skeletal muscle regeneration
por: Xiong, Guangyan, et al.
Publicado: (2017)

Antagonism Between DUX4 and DUX4c Highlights a Pathomechanism Operating Through β-Catenin in Facioscapulohumeral Muscular Dystrophy
por: Ganassi, Massimo, et al.
Publicado: (2022)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
por: Starosta, Alicja, et al.
Publicado: (2021)

Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy
por: Ricci, Giulia, et al.
Publicado: (2022)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b20m280d3gsljevud2tth6lq4v